Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2021-04-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2020年度独立董事述职报告（王秀萍）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2020, detailing attendance at board and shareholder meetings, opinions on various board matters, supervision of company governance, and other related activities. It is a detailed report on board/management activities and governance oversight rather than a financial report or announcement. The content focuses on the director's duties, opinions, and governance role, which aligns with Board/Management Information filings. The document length (6939 characters) and detailed content confirm it is a substantive report, not a brief announcement or certification. Therefore, the appropriate classification is Board/Management Information (MANG).
2021-04-28 Chinese
2020年度独立董事述职报告（汪思佳）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2020 Annual Work Report" for Chengdu Berry Genomics Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on various company matters, supervision of information disclosure, governance activities, and other duties performed during the year 2020. The content is a detailed report of the independent director's activities and responsibilities over the year, which aligns with a Management Report or similar governance-related reporting. It is not an Annual Report (10-K), Audit Report, or any other financial statement. It is also not a brief announcement or a proxy solicitation. The document is a detailed narrative report on management/governance activities by an independent director, fitting best under Board/Management Information (MANG). The document length is 4116 characters, which is substantive for such a report. Therefore, the classification is MANG with high confidence.
2021-04-28 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2020 by 成都市贝瑞和康基因技术股份有限公司. It discusses the company's internal control evaluation, including financial and non-financial internal control effectiveness, risk management, and control procedures. The document is detailed and contains substantive content about internal control systems, risk areas, and management responsibilities. It is not an announcement or a brief summary but a full report on internal control evaluation. This type of document aligns with an Audit Report / Information (AR) category, which includes standalone audit reports and internal control evaluations. It is not an Annual Report (10-K) or Interim Report (IR) as it focuses specifically on internal control evaluation rather than full financial performance. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains the full report content, not just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2020
2021-04-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 8th meeting of the 9th Board of Directors of the company. It includes approvals of the 2020 annual report, 2021 Q1 report, financial statements, work reports, audit firm appointment, related party transactions, profit distribution plan, accounting policy changes, and the scheduling of the 2020 annual shareholders meeting. The document is a formal board meeting resolution announcement, not the reports themselves, and it references that the full reports are disclosed elsewhere. The document length is 3580 characters, which is relatively short and mainly summarizes board decisions rather than providing full financial data or detailed reports. This fits the category of Board/Management Information (MANG) as it announces board meeting resolutions and management decisions.
2021-04-28 Chinese
2020年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as a '2020 Annual Report Summary' from a publicly listed company (stock code 000710) on the Shenzhen Stock Exchange. It contains detailed financial data for the year 2020, including revenue, net profit, earnings per share, and asset information. It also includes business descriptions, product and service details, and shareholder information. The length is substantial (15,000 characters) and contains actual financial statements and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K) rather than a brief summary or announcement. FY 2020
2021-04-28 Chinese
2020年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2020年度业绩快报' which translates to '2020 Annual Performance Express Report' or 'Earnings Quick Report'. It contains preliminary financial data for the year 2020, including revenue, profit, net income, earnings per share, and other financial metrics. The document explicitly states that the data is preliminary and unaudited, and that final audited data will be disclosed in the annual report. The length of the document is 2843 characters, which is relatively short and typical for an earnings release or earnings quick report rather than a full annual report. There is no indication that this is a full annual report (10-K) or audit report (AR). It is not a report publication announcement (RPA) because it contains substantive financial data, not just a notice. The document is not a management discussion and analysis (MDA) or investor presentation (IP) as it lacks detailed narrative or presentation format. The document is a preliminary earnings release (ER) providing key financial highlights for the fiscal year 2020. Therefore, the most appropriate classification is Earnings Release (ER). FY 2020
2021-04-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.